Perioperative cefuroxime pharmacokinetics in cardiac surgery

Clinics

Volumn 62, Issue 3, 2007, Pages 257-260

  Nascimento, Jorge Willian Leandro ^a   Carmona, Maria José Carvalho ^a   Strabelli, Tânia Mara Varejão ^a   Auler Jr , José Otávio Costa ^a   Santos, Sílvia Regina Cavani Jorge ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Antibiotic prophylaxis; Cefuroxime; Heart surgery; HPLC; Pharmacokinetics

Indexed keywords

EID: 34347211058     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1807-59322007000300009     Document Type: Article

References (12)

1. Turna A, Kutlu CA, Ozalp T, Karamustafaoglu A, Mulazimoglu L, Bedirhan MA. Antibiotic prophylaxis in elective thoracic surgery: cefuroxime versus cefepime. Thorac Cardiovasc Surg. 2003;51:84-8.
2. (no authors listed) Current trends in antibiotic prophylaxis in surgery. Surgery. 2000;128:S14-8.
3. Emmerson AM. Cefuroxime axetil. J Antimicrob Chemother. 1988;22:101-4.
4. Harbi M. Antimicrobial prophylactic practice in surgical patients. East Afr Med J. 1998;75:703-07.
5. Nascimento JWL, Omosako CE, Carmona MJ, Auler Junior JOC, Santos SRCJ. Micromethod for plasma cefuroxime quantification through high performace liquid chromatography. Application to the prophylaxis of patients submitted to cardiac surgery. Braz J Pharmac Sci. 2003;39:265-72.
6. Jakob HG, Borneff-Lipp M, Bach A, von Puckler S, Windeler J, Sonntag H, et al. The endogenous pathway is a major route for deep sternal wound infection. Eur J Cardiothorac Surg. 2000;17:154-60.
7. Kriaras I, Michalopoulos A, Michalis A, Palatianos G, Economopoulos G, Anagnostopoulos C, et al. Antibiotic prophylaxis in cardiac surgery. J Cardiovasc Surg. 1997;38:605-10.
8. Pass SE, Miyagawa CI, Healy DP, Ivey TD. Serum concentrations of cefuroxime after continuous infusion in coronary bypass graft patients. Ann Pharmacother. 2001;35:409-13.
9. Jacobs MR. Optimisation of antimicrobial therapy using pharmacokinetic and pharmacodynamic parameters. Clin Microbiol Infect. 2001;7:589-96.
10. Trick WE, Scheckler WE, Tokars JI, Jones KC, Reppen ML, Smith EM, et al. Modifiable risk factors associated with deep sternal site infection after coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2000;119:108-14.
11. Wenisch C, Bartunek A, Zedtwitz-Liebenstein K, Hiesmayr M, Parschalk B, Pernerstorfer T, et al. Prospective randomized comparison of cefodizime versus cefuroxime for perioperative prophylaxis in patients undergoing coronary artery bypass grafting. Antimicrob Agents. 1997;41:1584-8.
12. Craig WA, Ebert SC. Continuous infusion of beta-lactam antibiotics. Antimicrob Agents Chemother. 1992;36:2577-83.